Red blood cell distribution width predicts survival in patients with Eisenmenger syndrome

Clinical Chemistry and Laboratory Medicine

Volumn 52, Issue 5, 2014, Pages 743-750

  Yang, Tao ^a   Sun, Yun Juan ^b   Xiong, Chang Ming ^a   Zeng, Wei Jie ^c   Ni, Xin Hai ^a   Zhao, Zhi Hui ^a   Liu, Zhi Hong ^a   Gu, Qing ^a   He, Jian Guo ^a  

^a FUWAI HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Eisenmenger syndrome; red blood cell distribution width; survival

Indexed keywords

ADULT; ARTERIAL OXYGEN SATURATION; ARTICLE; CELLULAR DISTRIBUTION; EISENMENGER COMPLEX; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LUNG ARTERY PRESSURE; LUNG RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEAN PULMONARY ARTERIAL PRESSURE; MEDICAL RECORD REVIEW; MIXED VENOUS OXYGEN SATURATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RED BLOOD CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; VENOUS OXYGEN TENSION; AREA UNDER THE CURVE; BLOOD; CHEMISTRY; COMPLICATION; CYTOLOGY; FAMILIAL PRIMARY PULMONARY HYPERTENSION; KAPLAN MEIER METHOD; MEAN CORPUSCULAR VOLUME; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS;

OXYGEN;

ADULT; AREA UNDER CURVE; EISENMENGER COMPLEX; ERYTHROCYTE INDICES; ERYTHROCYTES; FAMILIAL PRIMARY PULMONARY HYPERTENSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; OXYGEN; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84898946840     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0747     Document Type: Article

References (24)

1. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
2. Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, et al. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999;84:677-81. (Pubitemid 29417960)
3. Van De Bruaene A, De Meester P, Voigt JU, Delcroix M, Pasquet A, De Backer J, et al. Right ventricular function in patients with Eisenmenger syndrome. Am J Cardiol 2012;109:1206-11.
4. Moceri P, Dimopoulos K, Liodakis E, Germanakis I, Kempny A, Diller GP, et al. Echocardiographic predictors of outcome in Eisenmenger syndrome. Circulation 2012;126:1461-8.
5. Van De Bruaene A, Delcroix M, Pasquet A, De Backer J, De Pauw M, Naeije R, et al. Iron deficiency is associated with adverse outcome in Eisenmenger patients. Eur Heart J 2011;32:2790-9.
6. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006;27: 1737-42. (Pubitemid 44025362)
7. Oya H, Nagaya N, Satoh T, Sakamaki F, Kyotani S, Fujita M, et al. Haemodynamic correlates and prognostic significance of serum uric acid in adult patients with Eisenmenger syndrome. Heart 2000;84:53-8. (Pubitemid 30429222)
8. Reardon LC, Williams RJ, Houser LS, Miner PD, Child JS, Aboulhosn JA. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. Am J Cardiol 2012;110:1523-6.
9. Reardon LC, Williams RJ, Houser LS, Miner PD, Child JS, Aboulhosn JA. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart 2012;98:736-42.
10. van Kimmenade RR, Mohammed AA, Uthamalingam S, van der Meer P, Felker GM, Januzzi JL Jr. Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail 2010;12:129-36.
11. Gul M, Uyarel H, Ergelen M, Karacimen D, Ugur M, Turer A, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis 2012;23:330-6.
12. Zorlu A, Bektasoglu G, Guven FM, Dogan OT, Gucuk E, Ege MR, et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol 2012;109:128-34.
13. Montagnana M, Cervellin G, Meschi T, Lippi G. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med 2011;50:635-41.
14. Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol 2009;104:868-72.
15. Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 2011;97:1054-60.
16. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003;167:1287.
17. Perkins SL. Examination of blood and bone marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE, editors. Wintrobe's Clinical Hematology, 11th ed. Salt Lake City, Utah: Lippincott Wilkins & Williams, 2003:5-25.
18. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010;121:20-5.
19. Manes A, Palazzini M, Leci E, Bacchi Reggiani ML, Branzi A, Galiè N. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J Epub ahead of print 1 Mar 2013. DOI:10.1093/eurheartj/ eht072.
20. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986;2:313-5. (Pubitemid 16069615)
21. Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol 2011;151:307-12.
22. Van Craenenbroeck EM, Pelle AJ, Beckers PJ, Possemiers NM, Ramakers C, Vrints CJ, et al. Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure. Eur J Heart Fail 2012;14:54-60.
23. Makhoul BF, Khourieh A, Kaplan M, Bahouth F, Aronson D, Azzam ZS. Relation between changes in red cell distribution width and clinical outcomes in acute decompensated heart failure. Int J Cardiol 2013;167:1412-6.
24. Van Craenenbroeck EM, Conraads VM, Greenlaw N, Gaudesius G, Mori C, Ponikowski P, et al. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study. Eur J Heart Fail 2013;15:756-62.